More articles from Basic Science I: Neurodegenerative Disorders and Others

You have access
Neuroimaging of inflammation: high fat-induced exacerbation of Alzheimer disease
Hsin-Hsien Yeh, Chien-Hung Li, Ya-Yao Huang, Fong-Lee Huang, Huey-Jen Tsay and Wen-Sheng Huang

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 273;
You have access
Comparison analysis of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents ¹⁸F-flutemetamol and ¹⁸F-florbetaben
Hye Joo Son, Do-Young Kang, Young Jin Jeong, Hyun Jin Yoon, Yong Jin Lee, Min Hwan Kim, Munki Kim, SungA Kang, Go-eun Choi, Jieun Jeong, Su Jung Choi, Kyo Chul Lee, Jiae Park and Sang Yeun Lee

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 278;
You have access
Direct synthesis of [11C]MAR, a novel PET tracer for imaging of glycogen synthase kinase-3 (GSK-3) activity
Javier Giglio, Fernandez Soledad, Maia Zeni, Ana Laura Reyes, Patricia Oliver, Valle Palomo, Ana MartÃnez, Ana Rey, Hugo Cerecetto and Henry Engler

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 279;
You have access
Quantification of [¹⁸F]MK-6240, a new PET tracer targeting human neurofibrillary tangles (NFTs) in brain of healthy elderly and subjects with Alzheimer’s disease.
Talakad Lohith, Idriss Bennacef, Cyrille Sur, Ruben Declercq, Kim Serdons, Guy Bormans, Eric Hostetler, Koen Van Laere, Rik Vandenberghe and Arie Struyk

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 277;
You have access
Evaluation of a novel PET radioligand for imaging O-linked-N-acetyl-glucosamine hydrolase (O-GlcNAcase) in monkeys and mice
Jeih-San Liow, Mohammad Haskali, Soumen Paul, Sami Zoghbi, Susan DuBois, Vanessa Barth, Marcy Comly, Michelle Bond, Cheryl Morse, Robert Gladding, Nancy Kant, Sergey Shcherbinin, Hugh Nuthall, Paolo Zanotti Fregonara, John Hanover, Cynthia Jesudason, Victor Pike and Robert Innis

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 272;
You have access
Evaluating the allograft effects of Sertoli cells and embryonic VM tissues in a Parkinsonian rat model using [¹⁸F]FE-PE2I/animal-PET
Cheng-Yi Cheng, Yun-Ting Jhao, Ta-Kai Chou, Shao-Ju Weng, Ya-Yao Huang, Ruoh-Fang Yen, Chyng-Yann Shiue and Kuo-Hsing Ma

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 271;
You have access
Evaluation of a novel, selective M1 muscarinic acetylcholine receptor ligand ¹¹C-LSN3172176 in non-human primates
Nabeel Nabulsi, Daniel Holden, Ming-Qiang Zheng, Lawrence Slieker, Vanessa Barth, Shu-fei Lin, Nancy Kant, Cynthia Jesudason, David Labaree, Anupama Shirali, Richard Carson and Yiyun Huang

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 275;
You have access
PET imaging of Dopamine Transporter with ¹⁸F-LBT999: first human exploration
Nicolas ARLICOT, Johnny VERCOUILLIE, CÃ©cile MALHERBE, Rudy BIDAULT, ValÃ©rie GISSOT, Serge MAIA, Laurent BARANTIN, Jean-Philippe COTTIER, Jean-Bernard DELOYE, Denis GUILLOTEAU and Maria-Joao RIBEIRO

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 276;
You have access
Synthesis and in vitro and in vivo evaluation of a novel radioligand for LRRK2
Noeen Malik, Daniel Tuchman, Johan Sandell, Andrew Gifford and Yu-Shin Ding

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 274;

Main menu

User menu

Search

More articles from Basic Science I: Neurodegenerative Disorders and Others